Kurt Jacobson, MD
Interventional Cardiology · Madison, WINPI 1518947712
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,100 of the $24,401 with a category attached, or 70.1%. Medtronic accounts for 89.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $14,663 and has fallen 99.4% since, to $90 in 2025.
Across 44 payments — averaging $554.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$22K
- Boston Scientific$811
- Edwards Lifesciences$669
- W. L. Gore & Associates, Inc.$600
- Angiodynamics, Inc.$471
- Abbott$90
Across 91 payments — averaging $2217.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$122K
- Boston Scientific$79K
What the payments were for
- Consulting fees$3501%
- Speaking & faculty fees$17,10070%
- Travel & lodging$5,91524%
- Food & beverage$1,0354%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 37 | $21,759 |
| Boston Scientific | 2 | $811 |
| Edwards Lifesciences | 1 | $669 |
| W. L. Gore & Associates, Inc. | 1 | $600 |
| Angiodynamics, Inc. | 2 | $471 |
| Abbott | 1 | $90 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,401 in reported general payments places this provider in the 80th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 46 | $52,016 |
| EliquisApixaban | 58 | $45,200 |
| FarxigaDapagliflozin Propanediol | 60 | $37,633 |
| Repatha SureclickEvolocumab | 52 | $32,064 |
| XareltoRivaroxaban | 14 | $19,620 |
| Metoprolol Succinate | 65 | $916 |
| Atorvastatin Calcium | 89 | $853 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 70 | $794 |
| ClopidogrelClopidogrel Bisulfate | 45 | $735 |
| Flecainide Acetate | 13 | $701 |
| Rosuvastatin Calcium | 49 | $700 |
| Ezetimibe | 25 | $584 |
| Valsartan | 32 | $571 |
| Lisinopril | 21 | $359 |
| Furosemide | 49 | $304 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Madison
- Amish RavalMadison$21K
- James BallardMadison$8K
- Alexandra ErdmannMadison$7K
- Benjamin CiskeMadison$5K
- Giorgio GimelliMadison$5K
- Michael SalingerMilwaukee$216K
- Arun KalyanasundaramMarshfield$201K
- Michael RosenbergManitowoc$111K
- Tanvir BajwaMilwaukee$106K
- Suhail AllaqabandMilwaukee$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.